Clinical Trials Browser

Phase 2 × Carcinoma, Pancreatic Ductal × 90 days × Clear all

NCT07259317 2026-04-23

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma, Carcinoma, Pancreatic Ductal

NCT06850623 2026-04-03

ENACT

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal